These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 23593992)
1. Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track? Esposito Z; Belli L; Toniolo S; Sancesario G; Bianconi C; Martorana A CNS Neurosci Ther; 2013 Aug; 19(8):549-55. PubMed ID: 23593992 [TBL] [Abstract][Full Text] [Related]
2. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia]. Tanović A; Alfaro V Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529 [TBL] [Abstract][Full Text] [Related]
3. Memantine: targeting glutamate excitotoxicity in Alzheimer's disease and other dementias. Molinuevo JL; Lladó A; Rami L Am J Alzheimers Dis Other Demen; 2005; 20(2):77-85. PubMed ID: 15844753 [TBL] [Abstract][Full Text] [Related]
11. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies. Tariot PN J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40). Miguel-Hidalgo JJ; Alvarez XA; Cacabelos R; Quack G Brain Res; 2002 Dec; 958(1):210-21. PubMed ID: 12468047 [TBL] [Abstract][Full Text] [Related]
13. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders. Lipton SA J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416 [TBL] [Abstract][Full Text] [Related]
14. Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets. Zádori D; Veres G; Szalárdy L; Klivényi P; Toldi J; Vécsei L J Alzheimers Dis; 2014; 42 Suppl 3():S177-87. PubMed ID: 24670398 [TBL] [Abstract][Full Text] [Related]
15. An update on drug treatment options of Alzheimer's disease. Allgaier M; Allgaier C Front Biosci (Landmark Ed); 2014 Jun; 19(8):1345-54. PubMed ID: 24896354 [TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections. Danysz W; Parsons CG Br J Pharmacol; 2012 Sep; 167(2):324-52. PubMed ID: 22646481 [TBL] [Abstract][Full Text] [Related]
19. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. Rogawski MA; Wenk GL CNS Drug Rev; 2003; 9(3):275-308. PubMed ID: 14530799 [TBL] [Abstract][Full Text] [Related]
20. [Efficacy of memantine in the treatment of Alzheimer's disease]. Molinuevo Guix JL; Lladó Plarrumaní A Neurologia; 2005 Dec; 20(10):686-91. PubMed ID: 16317590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]